Platelets Contribute to Circulating Levels of Dickkopf-1 (Dkk-1): Clinical Implications in Multiple Myeloma.

被引：0
|
作者：
Voorzanger-Rousselot, N. [1 ]
Goehrig, D. [2 ]
Clezardin, P. [2 ]
Facon, T. [3 ]
Garnero, P. [1 ,2 ]
机构：
[1] SYNARC, Mol Markers, Lyon, France
[2] INSERM, U664, F-69008 Lyon, France
[3] CHRU, Hop Huriez, Serv Malad Sang, Lille, France
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [41] Dickkopf-1 (Dkk-1) Is a New Agonist of the Orphan Receptor Tyrosine Kinase Ror-2 in Intestinal Epithelia.
    Pacheco, I. I.
    Kelly, J.
    MacLeod, R. J.
    MODERN PATHOLOGY, 2011, 24 : 396A - 396A
  • [42] Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma
    Choi, Yong Won
    Park, Joon Seong
    Han, Jae Ho
    Kim, Jang-Hee
    Ahn, Mi Sun
    Lee, Hyun Woo
    Kang, Seok Yun
    Choi, Jin-Hyuk
    Jeong, Seong Hyun
    LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2670 - 2678
  • [43] Strong Immunoexpression of Dickkopf-1 Is Associated with Response to Bortezomib in Multiple Myeloma
    Choi, Yong Won
    Kim, Tae Hwan
    Jeong, Seong Hyun
    Han, Jae Ho
    Park, Joon Seong
    BLOOD, 2016, 128 (22)
  • [44] The effect of dickkopf-1 (DKK-1) on prostate cancer growth and bone metastasis using the canine osteoblastic Probasco cell line
    Yuan, Shiyu
    Hoggard, Nathan K.
    Kantake, Noriko
    Hildreth, Blake E.
    Rosol, Thomas J.
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Bortezomib reduces serum dickkopf-1 and RANKL concentrations and normalizes indices of bone remodeling in patients with relapsed multiple myeloma.
    Terpos, Evangelos
    Heath, Deborah
    Rahemtulla, Amin
    Zervas, Kostas
    Chantry, Andrew
    Anagnostopoulos, Athanasios
    Pouli, Anastasia
    Katodritou, Eirini
    Verrou, Evgenia
    Vervessou, Elisavet C.
    Dimopoulos, Meletios A.
    Croucher, Peter
    BLOOD, 2006, 108 (11) : 153A - 153A
  • [46] Bone Marrow DKK-1 Levels Identify Patients With Smoldering Myeloma With Higher Risk of Progression to Active Multiple Myeloma
    Giuliani, Nicola
    Palma, Benedetta Dalla
    Marchica, Valentina
    Accardi, Fabrizio
    Notarfranchi, Laura
    Costa, Federica
    De Luca, Federica
    Guasco, Daniela
    Pedrazzoni, Mario
    Aversa, Franco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E35 - E35
  • [47] Inhibition of dickkopf-1 (DKK-1) suppresses prostate cancer growth in vivo through induction of p21/CIP-1
    Hall, Christopher L.
    Baile, Shobun
    Zhang, Honglai
    Keller, Evan T.
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 894 - 894
  • [48] Serum concentrations of DKK-1 correlate with the extent of bone disease in multiple myeloma
    Kaiser, Martin
    Mieth, Maren
    Liebisch, Peter
    Rotzer, Susanne
    Peters, Malte
    Sezer, Orhan
    Heider, Ulrike
    Jakob, Christian
    Fleissner, Claudia
    Braendle, Edgar
    Stover, David
    BLOOD, 2007, 110 (11) : 1030A - 1030A
  • [49] Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma
    Eldeeb, Mona Kamal
    Magour, Gehan Mahmoud
    Bedair, Rania Nabil
    Shamseya, Mohammed Mahmoud
    Hammouda, Mennatallah Abdelfattah
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (02) : 85 - 91
  • [50] Human PC-3 prostate cancer cells inhibit osteoblast-mediated mineralization through Dickkopf-1 (DKK-1)
    Hall, CL
    Keller, ET
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P13 - P14
12345